Investigational new drugGLP-1
Compound 61846
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061846
Risk Class
HIGH
Last Audit
Aug 31, 2108
Research Abstract
GLP-1 candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61846 is a glp-1 asset inside glp-1 innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061846 with updates logged 2108-08-31.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61846GLP-1 Program 61846
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061846
- [2] Operations Pulse • GLP-1 innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61846